Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.
Naruto TairaMasataka SawakiYukari UemuraTsuyoshi SaitoShinichi BabaKokoro KobayashiHiroaki KawashimaMichiko TsuneizumiNoriko SagawaHiroko BandoMasato TakahashiMiki YamaguchiTsutomu TakashimaTakahiro NakayamaMasahiro KashiwabaToshiro MizunoYutaka YamamotoHiroji IwataYasuo OhashiHirofumi MukaiTakuya Kawaharanull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Detrimental effects of adjuvant chemotherapy on global QoL, morale, and activity capacity lasted for at least 12 months but were not observed at 36 months.